AIMC Topic: Prostatic Neoplasms, Castration-Resistant

Clear Filters Showing 11 to 14 of 14 articles

Using Machine Learning to Predict Survival in Patients with Metastatic Castration-Resistant Prostate Cancer.

Studies in health technology and informatics
Non-specific clinical biomarkers have been shown to help identify prognostic risks in cancer patients. However, the accuracy of prognostic biomarkers for predicting survival in patients with metastatic castration-resistant prostate cancer (mCRPC) sti...

Pilot study of an artificial intelligence-based deep learning algorithm to predict time to castration-resistant prostate cancer for metastatic hormone-naïve prostate cancer.

Japanese journal of clinical oncology
The object in this study is to develop an artificial intelligence-based deep learning algorithm for prediction of time to castration-resistant prostate cancer by combined androgen blockade therapy in metastatic hormone-naïve prostate cancer. We inclu...

[Down-regulated PTTG1 expression promotes the senescence of human prostate cancer LNCaP-AI].

Zhonghua nan ke xue = National journal of andrology
OBJECTIVE: To investigate the effect of the down-regulated expression of pituitary tumor-transforming gene 1 (PTTG1) on the senescence of human castration-resistant prostate cancer LNCaP-AI cells.

Hematopoiesis is prognostic for toxicity and survival of Radium treatment in patients with metastatic castration-resistant prostate cancer.

Hellenic journal of nuclear medicine
OBJECTIVE: We evaluated the impact of pre-therapeutic hematopoiesis on survival, hematotoxicity (HT) and number of Radium (Ra) treatments in patients with metastatic castration-resistant prostate cancer.